MWB Consulting
MWB Consulting is recorded as a service provider in 1 clinical trial. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 1 of 1 trials · Latest update first
A Phase 1b/2, Open-label, Randomized Study of Vudalimab in Combination With Chemotherapy or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced Non-small Cell Lung Cancer
Sponsor Xencor Inc.
- Start (EU)
- Latest update
- Estimated end
Operational learnings available3 trial-level findings · Read insights
- Twenty-two clinical sites enrolled subjects across Belgium, Greece, Malaysia, the Netherlands, Portugal, Spain, Taiwan, and the United States.
- After review of data from the first two subjects enrolled at 750 mg, the IMC modified Part 1 randomization so that subsequently enrolled subjects received either 500 mg or 750 mg.
- After reviewing 28 randomized and treated Part 1 subjects, the IMC recommended ending enrollment and not initiating Part 2.
These findings describe the trial, not the service provider’s performance or responsibility.
Questions about this trial experience
What services are recorded for MWB Consulting?
The 2026-10-09 snapshot links MWB Consulting to 1 distinct CTIS trials. Recorded services include EU Legal Representative, EudraVigilance Responsible Person, and Data Protection Officer (DPO). These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for MWB Consulting?
The most frequently recorded therapeutic areas are Solid Tumor Oncology. Recorded phases include Phase 1, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to MWB Consulting conducted?
The linked trials record locations in 7 countries, including Belgium, Spain, Greece, Netherlands, Poland. These are trial locations, not confirmed office locations or countries where MWB Consulting delivered services.
What can this page tell me about MWB Consulting's trial experience?
Browse 1 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under MWB Consulting. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- MWB Consulting